APA

Graziano F., Canestrari E., Loupakis F., Ruzzo A., Galluccio N., Santini D., Rocchi M., Vincenzi B., Salvatore L., Cremolini C., Spoto C., Catalano V., D'Emidio S., Giordani P., Tonini G., Falcone A. & Magnani M. (20110225). Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. : The pharmacogenomics journal.

Chicago

Graziano F, Canestrari E, Loupakis F, Ruzzo A, Galluccio N, Santini D, Rocchi M, Vincenzi B, Salvatore L, Cremolini C, Spoto C, Catalano V, D'Emidio S, Giordani P, Tonini G, Falcone A and Magnani M. 20110225. Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. : The pharmacogenomics journal.

Harvard

Graziano F., Canestrari E., Loupakis F., Ruzzo A., Galluccio N., Santini D., Rocchi M., Vincenzi B., Salvatore L., Cremolini C., Spoto C., Catalano V., D'Emidio S., Giordani P., Tonini G., Falcone A. and Magnani M. (20110225). Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. : The pharmacogenomics journal.

MLA

Graziano F, Canestrari E, Loupakis F, Ruzzo A, Galluccio N, Santini D, Rocchi M, Vincenzi B, Salvatore L, Cremolini C, Spoto C, Catalano V, D'Emidio S, Giordani P, Tonini G, Falcone A and Magnani M. Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. : The pharmacogenomics journal. 20110225.